Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Alzheimer Disease | 123 | 2023 | 7975 | 3.830 |
Why?
|
Dementia | 39 | 2023 | 2488 | 3.120 |
Why?
|
Apolipoproteins E | 25 | 2022 | 1437 | 1.630 |
Why?
|
Apolipoprotein E4 | 15 | 2022 | 669 | 1.630 |
Why?
|
Cognition Disorders | 33 | 2017 | 4026 | 1.490 |
Why?
|
Flavonoids | 2 | 2021 | 443 | 1.300 |
Why?
|
Genetic Linkage | 21 | 2008 | 2433 | 1.270 |
Why?
|
Cognition | 21 | 2023 | 6686 | 1.120 |
Why?
|
Neuropsychological Tests | 39 | 2022 | 6963 | 1.080 |
Why?
|
Amyloid beta-Peptides | 10 | 2019 | 3579 | 0.830 |
Why?
|
alpha-Macroglobulins | 5 | 2007 | 65 | 0.770 |
Why?
|
Bupropion | 1 | 2022 | 303 | 0.760 |
Why?
|
Stroke | 14 | 2023 | 9898 | 0.710 |
Why?
|
Genotype | 30 | 2020 | 12951 | 0.660 |
Why?
|
Brain | 25 | 2022 | 26345 | 0.640 |
Why?
|
Cerebrovascular Disorders | 5 | 2023 | 1497 | 0.620 |
Why?
|
Aged | 133 | 2023 | 162698 | 0.590 |
Why?
|
Leukoaraiosis | 1 | 2018 | 120 | 0.570 |
Why?
|
Microvessels | 1 | 2018 | 544 | 0.480 |
Why?
|
Epilepsy | 5 | 2022 | 3289 | 0.480 |
Why?
|
Cholinesterase Inhibitors | 4 | 2013 | 239 | 0.470 |
Why?
|
Inheritance Patterns | 3 | 2013 | 339 | 0.460 |
Why?
|
Psychiatric Status Rating Scales | 13 | 2017 | 6028 | 0.450 |
Why?
|
Electronic Health Records | 7 | 2023 | 4426 | 0.440 |
Why?
|
Humans | 220 | 2023 | 739398 | 0.440 |
Why?
|
Caregivers | 9 | 2022 | 2067 | 0.440 |
Why?
|
Aged, 80 and over | 76 | 2022 | 57650 | 0.430 |
Why?
|
Diet | 4 | 2022 | 7876 | 0.420 |
Why?
|
Polymorphism, Genetic | 12 | 2009 | 4332 | 0.420 |
Why?
|
Genetic Testing | 13 | 2019 | 3441 | 0.410 |
Why?
|
Antipsychotic Agents | 5 | 2022 | 3055 | 0.410 |
Why?
|
Genetic Predisposition to Disease | 32 | 2019 | 17384 | 0.400 |
Why?
|
Longitudinal Studies | 29 | 2021 | 13880 | 0.380 |
Why?
|
Apolipoprotein E2 | 2 | 2007 | 127 | 0.370 |
Why?
|
Models, Statistical | 10 | 2021 | 5113 | 0.370 |
Why?
|
Male | 126 | 2023 | 349022 | 0.360 |
Why?
|
Principal Component Analysis | 1 | 2013 | 937 | 0.360 |
Why?
|
Hypertension | 4 | 2023 | 8431 | 0.360 |
Why?
|
Female | 129 | 2023 | 378853 | 0.350 |
Why?
|
Lod Score | 10 | 2011 | 615 | 0.340 |
Why?
|
Diet Surveys | 3 | 2022 | 1165 | 0.340 |
Why?
|
Interview, Psychological | 3 | 2011 | 812 | 0.340 |
Why?
|
Nuclear Family | 7 | 2006 | 318 | 0.330 |
Why?
|
Age of Onset | 21 | 2015 | 3263 | 0.320 |
Why?
|
Peptide Fragments | 3 | 2018 | 5076 | 0.320 |
Why?
|
Indans | 2 | 2006 | 96 | 0.310 |
Why?
|
Aging | 12 | 2023 | 8613 | 0.310 |
Why?
|
Temporal Lobe | 8 | 2017 | 1671 | 0.310 |
Why?
|
Chromosome Mapping | 11 | 2011 | 4743 | 0.300 |
Why?
|
Memory | 5 | 2020 | 2161 | 0.290 |
Why?
|
Gene Frequency | 14 | 2017 | 3585 | 0.280 |
Why?
|
Models, Genetic | 9 | 2011 | 3493 | 0.280 |
Why?
|
Lipid Metabolism | 2 | 2019 | 1891 | 0.270 |
Why?
|
Cerebral Hemorrhage | 4 | 2022 | 2627 | 0.270 |
Why?
|
Interviews as Topic | 1 | 2012 | 2533 | 0.260 |
Why?
|
Social Participation | 3 | 2021 | 171 | 0.250 |
Why?
|
Cohort Studies | 29 | 2022 | 40389 | 0.250 |
Why?
|
Activities of Daily Living | 7 | 2021 | 2410 | 0.250 |
Why?
|
Risk Factors | 36 | 2023 | 71974 | 0.240 |
Why?
|
Blood Pressure | 6 | 2023 | 8554 | 0.240 |
Why?
|
Middle Aged | 62 | 2023 | 212863 | 0.230 |
Why?
|
Chromosomes, Human | 3 | 2011 | 456 | 0.230 |
Why?
|
Pedigree | 11 | 2015 | 4640 | 0.230 |
Why?
|
Magnetic Resonance Imaging | 25 | 2022 | 35326 | 0.230 |
Why?
|
Disease Progression | 17 | 2021 | 13237 | 0.220 |
Why?
|
Anticonvulsants | 3 | 2021 | 1907 | 0.220 |
Why?
|
Emergency Medical Services | 1 | 2014 | 1904 | 0.220 |
Why?
|
Polymorphism, Single Nucleotide | 18 | 2018 | 15500 | 0.220 |
Why?
|
Bipolar Disorder | 7 | 2006 | 5023 | 0.220 |
Why?
|
Delirium | 3 | 2022 | 1604 | 0.220 |
Why?
|
Cerebral Amyloid Angiopathy | 3 | 2017 | 851 | 0.210 |
Why?
|
Linkage Disequilibrium | 13 | 2017 | 1992 | 0.210 |
Why?
|
Genetic Loci | 3 | 2019 | 2567 | 0.210 |
Why?
|
Seizures | 3 | 2022 | 2829 | 0.210 |
Why?
|
Genetic Markers | 11 | 2023 | 2630 | 0.210 |
Why?
|
Exercise | 1 | 2018 | 5591 | 0.200 |
Why?
|
Haplotypes | 6 | 2020 | 2782 | 0.200 |
Why?
|
Depression | 7 | 2019 | 7689 | 0.200 |
Why?
|
International Classification of Diseases | 3 | 2022 | 867 | 0.200 |
Why?
|
Memantine | 2 | 2013 | 100 | 0.190 |
Why?
|
Mental Recall | 5 | 2014 | 1201 | 0.190 |
Why?
|
Meat Products | 1 | 2021 | 99 | 0.190 |
Why?
|
United States | 34 | 2022 | 69573 | 0.190 |
Why?
|
Infarction | 1 | 2022 | 242 | 0.190 |
Why?
|
National Institute of Mental Health (U.S.) | 5 | 2011 | 106 | 0.190 |
Why?
|
Vitamin E | 1 | 2005 | 870 | 0.190 |
Why?
|
Hypotension, Orthostatic | 1 | 2023 | 258 | 0.190 |
Why?
|
Educational Status | 5 | 2022 | 2514 | 0.190 |
Why?
|
Tissue Plasminogen Activator | 2 | 2012 | 1263 | 0.180 |
Why?
|
Chromosomes, Human, Pair 10 | 4 | 2007 | 287 | 0.180 |
Why?
|
Alleles | 13 | 2020 | 6942 | 0.180 |
Why?
|
Piperidines | 2 | 2006 | 1597 | 0.180 |
Why?
|
Entorhinal Cortex | 3 | 2017 | 266 | 0.180 |
Why?
|
Genetics, Medical | 2 | 2005 | 340 | 0.180 |
Why?
|
Neurofibrillary Tangles | 2 | 2021 | 435 | 0.170 |
Why?
|
Genome-Wide Association Study | 11 | 2023 | 12178 | 0.170 |
Why?
|
Teaching Rounds | 1 | 2023 | 252 | 0.170 |
Why?
|
Medicare | 8 | 2022 | 6497 | 0.170 |
Why?
|
Parietal Lobe | 3 | 2008 | 834 | 0.170 |
Why?
|
Parkinson Disease | 2 | 2023 | 2780 | 0.170 |
Why?
|
Nerve Fibers, Myelinated | 3 | 2011 | 964 | 0.170 |
Why?
|
Ultrasonography, Doppler, Transcranial | 1 | 2000 | 302 | 0.170 |
Why?
|
Predictive Value of Tests | 13 | 2017 | 15036 | 0.170 |
Why?
|
Quantitative Trait Loci | 4 | 2011 | 2016 | 0.170 |
Why?
|
Cross-Sectional Studies | 16 | 2023 | 24714 | 0.170 |
Why?
|
Adaptor Proteins, Signal Transducing | 4 | 2017 | 2910 | 0.160 |
Why?
|
Proportional Hazards Models | 11 | 2017 | 12328 | 0.160 |
Why?
|
Leukoencephalopathies | 1 | 2021 | 237 | 0.160 |
Why?
|
tau Proteins | 2 | 2019 | 1861 | 0.160 |
Why?
|
Age Factors | 11 | 2021 | 18349 | 0.160 |
Why?
|
Mental Status Schedule | 7 | 2014 | 321 | 0.160 |
Why?
|
Alcoholism | 4 | 2004 | 1892 | 0.160 |
Why?
|
Preoperative Care | 2 | 2017 | 2238 | 0.160 |
Why?
|
Brain Ischemia | 2 | 2022 | 3246 | 0.150 |
Why?
|
Case-Control Studies | 15 | 2020 | 21694 | 0.150 |
Why?
|
Geriatric Assessment | 4 | 2016 | 1366 | 0.150 |
Why?
|
Hypotension | 1 | 2023 | 881 | 0.150 |
Why?
|
Algorithms | 12 | 2023 | 13872 | 0.150 |
Why?
|
Phospholipase C gamma | 1 | 2017 | 128 | 0.150 |
Why?
|
Genome, Human | 4 | 2008 | 4419 | 0.150 |
Why?
|
Atrophy | 8 | 2017 | 1571 | 0.150 |
Why?
|
Research Design | 6 | 2021 | 5959 | 0.150 |
Why?
|
Fibrinolytic Agents | 2 | 2012 | 2149 | 0.150 |
Why?
|
Nootropic Agents | 2 | 2010 | 160 | 0.150 |
Why?
|
Family | 9 | 2008 | 3141 | 0.140 |
Why?
|
Causality | 3 | 2023 | 1262 | 0.140 |
Why?
|
Olfactory Perception | 1 | 2016 | 53 | 0.140 |
Why?
|
Dietary Proteins | 1 | 2022 | 959 | 0.140 |
Why?
|
Early Diagnosis | 1 | 2021 | 1186 | 0.140 |
Why?
|
Exons | 3 | 2001 | 2430 | 0.140 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 1997 | 245 | 0.140 |
Why?
|
Decision Support Techniques | 2 | 2021 | 1957 | 0.140 |
Why?
|
Folic Acid | 1 | 2023 | 1297 | 0.140 |
Why?
|
Netherlands | 2 | 2020 | 2169 | 0.140 |
Why?
|
Follow-Up Studies | 18 | 2023 | 38942 | 0.140 |
Why?
|
Demography | 4 | 2014 | 1650 | 0.140 |
Why?
|
Plaque, Amyloid | 3 | 2016 | 728 | 0.140 |
Why?
|
Memory Disorders | 5 | 2011 | 1183 | 0.140 |
Why?
|
Probability | 2 | 2023 | 2500 | 0.140 |
Why?
|
Antidepressive Agents | 2 | 2022 | 2836 | 0.140 |
Why?
|
Calcium-Binding Proteins | 1 | 2000 | 1078 | 0.130 |
Why?
|
Metformin | 1 | 2022 | 827 | 0.130 |
Why?
|
Cerebral Cortex | 5 | 2011 | 5721 | 0.130 |
Why?
|
Cost of Illness | 3 | 2014 | 1849 | 0.130 |
Why?
|
Lewy Body Disease | 2 | 2008 | 223 | 0.130 |
Why?
|
Abbreviations as Topic | 1 | 2014 | 7 | 0.130 |
Why?
|
Cardiovascular Diseases | 5 | 2015 | 15070 | 0.130 |
Why?
|
Amyloid | 3 | 2022 | 794 | 0.130 |
Why?
|
Amyloidosis | 1 | 2022 | 789 | 0.130 |
Why?
|
Reproducibility of Results | 11 | 2022 | 19811 | 0.130 |
Why?
|
Hippocampus | 6 | 2016 | 3657 | 0.130 |
Why?
|
Remote Consultation | 1 | 1997 | 239 | 0.130 |
Why?
|
Depressive Disorder | 5 | 2019 | 3743 | 0.120 |
Why?
|
Odds Ratio | 8 | 2022 | 9846 | 0.120 |
Why?
|
Reference Values | 5 | 2008 | 4983 | 0.120 |
Why?
|
Antisocial Personality Disorder | 2 | 2006 | 227 | 0.120 |
Why?
|
Telephone | 1 | 1997 | 617 | 0.120 |
Why?
|
Social Behavior Disorders | 1 | 2014 | 97 | 0.120 |
Why?
|
Chromosomes, Human, Pair 12 | 4 | 2007 | 462 | 0.120 |
Why?
|
Conduct Disorder | 2 | 2006 | 241 | 0.110 |
Why?
|
Task Performance and Analysis | 2 | 2007 | 780 | 0.110 |
Why?
|
Chromosomes, Human, Pair 9 | 4 | 2009 | 537 | 0.110 |
Why?
|
Dementia, Vascular | 1 | 2014 | 127 | 0.110 |
Why?
|
Pancreatitis, Alcoholic | 1 | 2012 | 30 | 0.110 |
Why?
|
Amyloid beta-Protein Precursor | 2 | 2015 | 1121 | 0.110 |
Why?
|
Trypsinogen | 1 | 2012 | 83 | 0.110 |
Why?
|
Telomere | 1 | 2019 | 907 | 0.110 |
Why?
|
Immunity | 1 | 2019 | 1008 | 0.110 |
Why?
|
Patient Preference | 1 | 2020 | 881 | 0.110 |
Why?
|
Databases, Genetic | 3 | 2011 | 1777 | 0.110 |
Why?
|
Membrane Glycoproteins | 2 | 2017 | 3768 | 0.110 |
Why?
|
Diseases in Twins | 2 | 2004 | 449 | 0.110 |
Why?
|
Adult | 26 | 2022 | 213394 | 0.110 |
Why?
|
Health Care Costs | 5 | 2009 | 3226 | 0.110 |
Why?
|
Psychometrics | 4 | 2013 | 2995 | 0.100 |
Why?
|
Receptors, Immunologic | 2 | 2017 | 1424 | 0.100 |
Why?
|
Genetic Heterogeneity | 3 | 2011 | 727 | 0.100 |
Why?
|
Linear Models | 5 | 2017 | 5948 | 0.100 |
Why?
|
Claudins | 1 | 2012 | 110 | 0.100 |
Why?
|
Risk Assessment | 6 | 2021 | 23294 | 0.100 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2007 | 3908 | 0.100 |
Why?
|
Trypsin | 1 | 2012 | 507 | 0.100 |
Why?
|
Receptor, EphA1 | 1 | 2011 | 20 | 0.100 |
Why?
|
Menarche | 1 | 2014 | 513 | 0.100 |
Why?
|
Prospective Studies | 13 | 2023 | 53037 | 0.100 |
Why?
|
Australia | 1 | 2014 | 1162 | 0.100 |
Why?
|
Incidence | 6 | 2023 | 20913 | 0.100 |
Why?
|
Adolescent Development | 1 | 2014 | 274 | 0.100 |
Why?
|
National Institutes of Health (U.S.) | 1 | 1994 | 780 | 0.100 |
Why?
|
Monomeric Clathrin Assembly Proteins | 1 | 2010 | 24 | 0.100 |
Why?
|
Brain Diseases | 1 | 2020 | 1551 | 0.100 |
Why?
|
Membrane Proteins | 3 | 2011 | 7862 | 0.100 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 2013 | 449 | 0.090 |
Why?
|
Receptors, Complement 3b | 1 | 2010 | 145 | 0.090 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 2 | 2014 | 1951 | 0.090 |
Why?
|
Phenotype | 7 | 2020 | 16301 | 0.090 |
Why?
|
Clusterin | 1 | 2010 | 72 | 0.090 |
Why?
|
Time Factors | 10 | 2021 | 40050 | 0.090 |
Why?
|
Heat-Shock Proteins | 1 | 2014 | 825 | 0.090 |
Why?
|
Psychotic Disorders | 3 | 2018 | 3028 | 0.090 |
Why?
|
Body Weight | 1 | 2021 | 4660 | 0.090 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2011 | 293 | 0.090 |
Why?
|
Nerve Tissue Proteins | 3 | 2005 | 4463 | 0.090 |
Why?
|
Repressor Proteins | 1 | 2000 | 3007 | 0.090 |
Why?
|
Heterozygote | 3 | 2007 | 2798 | 0.090 |
Why?
|
Models, Psychological | 3 | 2009 | 809 | 0.090 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2023 | 2216 | 0.090 |
Why?
|
Positron-Emission Tomography | 4 | 2018 | 6361 | 0.080 |
Why?
|
Microglia | 1 | 2017 | 1248 | 0.080 |
Why?
|
Statistics as Topic | 3 | 2011 | 2373 | 0.080 |
Why?
|
Home Health Aides | 1 | 2008 | 15 | 0.080 |
Why?
|
DNA Methylation | 1 | 2023 | 4269 | 0.080 |
Why?
|
Severity of Illness Index | 10 | 2014 | 15511 | 0.080 |
Why?
|
Patient Selection | 1 | 2021 | 4211 | 0.080 |
Why?
|
Logistic Models | 8 | 2021 | 13402 | 0.080 |
Why?
|
Brain Chemistry | 1 | 2012 | 985 | 0.080 |
Why?
|
Statistics, Nonparametric | 5 | 2008 | 2881 | 0.080 |
Why?
|
Area Under Curve | 1 | 2012 | 1655 | 0.080 |
Why?
|
Brain Mapping | 6 | 2011 | 6666 | 0.080 |
Why?
|
ROC Curve | 2 | 2014 | 3526 | 0.080 |
Why?
|
Hormone Replacement Therapy | 1 | 2013 | 740 | 0.080 |
Why?
|
Leisure Activities | 1 | 2009 | 311 | 0.080 |
Why?
|
Lipids | 1 | 2019 | 3307 | 0.080 |
Why?
|
Atherosclerosis | 1 | 2023 | 3401 | 0.080 |
Why?
|
Self-Assessment | 1 | 2009 | 390 | 0.080 |
Why?
|
Orthopedic Procedures | 1 | 2017 | 1286 | 0.070 |
Why?
|
alpha Catenin | 1 | 2007 | 38 | 0.070 |
Why?
|
Prevalence | 8 | 2021 | 15153 | 0.070 |
Why?
|
Hormones | 1 | 2011 | 880 | 0.070 |
Why?
|
Gene Dosage | 2 | 2012 | 1251 | 0.070 |
Why?
|
Chromosomes, Human, Pair 8 | 2 | 2005 | 463 | 0.070 |
Why?
|
Physical Chromosome Mapping | 1 | 2007 | 183 | 0.070 |
Why?
|
Carrier Proteins | 2 | 2014 | 5012 | 0.070 |
Why?
|
Advisory Committees | 1 | 2011 | 770 | 0.070 |
Why?
|
Chromosomes, Human, Pair 6 | 2 | 2005 | 380 | 0.070 |
Why?
|
Nuclear Proteins | 2 | 2000 | 5830 | 0.070 |
Why?
|
Pattern Recognition, Visual | 3 | 2007 | 824 | 0.070 |
Why?
|
Asthma | 2 | 2006 | 5950 | 0.070 |
Why?
|
Database Management Systems | 1 | 2007 | 272 | 0.070 |
Why?
|
Pneumonia | 2 | 2015 | 2102 | 0.070 |
Why?
|
Hip Fractures | 1 | 2014 | 953 | 0.070 |
Why?
|
Attention Deficit and Disruptive Behavior Disorders | 1 | 2007 | 303 | 0.070 |
Why?
|
Twin Studies as Topic | 1 | 2005 | 105 | 0.070 |
Why?
|
3' Untranslated Regions | 2 | 2005 | 508 | 0.070 |
Why?
|
Sterol O-Acyltransferase | 1 | 2005 | 27 | 0.070 |
Why?
|
Pilot Projects | 3 | 2023 | 8275 | 0.070 |
Why?
|
Immunity, Innate | 1 | 2017 | 2950 | 0.060 |
Why?
|
Cytoskeletal Proteins | 1 | 2011 | 1369 | 0.060 |
Why?
|
Neuregulin-1 | 1 | 2005 | 141 | 0.060 |
Why?
|
Cause of Death | 1 | 2015 | 3564 | 0.060 |
Why?
|
Eating | 2 | 2022 | 1526 | 0.060 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 2 | 2008 | 1129 | 0.060 |
Why?
|
Cross-Cultural Comparison | 1 | 2008 | 648 | 0.060 |
Why?
|
Postmenopause | 1 | 2013 | 2456 | 0.060 |
Why?
|
Cathepsin D | 2 | 2001 | 61 | 0.060 |
Why?
|
Data Collection | 3 | 2012 | 3341 | 0.060 |
Why?
|
Clinical Trials as Topic | 2 | 2013 | 7897 | 0.060 |
Why?
|
Genetic Association Studies | 1 | 2013 | 2694 | 0.060 |
Why?
|
Delusions | 1 | 2005 | 300 | 0.060 |
Why?
|
Terminology as Topic | 2 | 2006 | 1548 | 0.060 |
Why?
|
Europe | 2 | 2020 | 3331 | 0.060 |
Why?
|
Imaging, Three-Dimensional | 2 | 2007 | 4035 | 0.060 |
Why?
|
Natural Language Processing | 2 | 2022 | 1024 | 0.060 |
Why?
|
Hallucinations | 1 | 2005 | 359 | 0.060 |
Why?
|
Regression Analysis | 4 | 2011 | 6452 | 0.050 |
Why?
|
Lipoproteins, LDL | 1 | 2005 | 626 | 0.050 |
Why?
|
Interleukin-6 | 1 | 2012 | 3194 | 0.050 |
Why?
|
Syndrome | 2 | 2006 | 3241 | 0.050 |
Why?
|
Thrombolytic Therapy | 1 | 2012 | 2155 | 0.050 |
Why?
|
Executive Function | 1 | 2011 | 1356 | 0.050 |
Why?
|
Focus Groups | 1 | 2007 | 1308 | 0.050 |
Why?
|
Homozygote | 2 | 2020 | 1788 | 0.050 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2011 | 8977 | 0.050 |
Why?
|
Proxy | 1 | 2022 | 144 | 0.050 |
Why?
|
Vitamin B 6 | 1 | 2023 | 237 | 0.050 |
Why?
|
Movement Disorders | 1 | 2005 | 445 | 0.050 |
Why?
|
Epidemiologic Methods | 1 | 2007 | 1364 | 0.050 |
Why?
|
Receptors, LDL | 1 | 2004 | 472 | 0.050 |
Why?
|
Public Health | 1 | 2014 | 2587 | 0.050 |
Why?
|
Aniline Compounds | 2 | 2017 | 990 | 0.050 |
Why?
|
Sulfonylurea Compounds | 1 | 2022 | 200 | 0.050 |
Why?
|
Home Care Services | 1 | 2008 | 602 | 0.050 |
Why?
|
Antihypertensive Agents | 1 | 2011 | 2039 | 0.050 |
Why?
|
Amyloidogenic Proteins | 1 | 2022 | 151 | 0.050 |
Why?
|
Insulysin | 1 | 2000 | 50 | 0.050 |
Why?
|
Delivery of Health Care | 2 | 2022 | 5272 | 0.050 |
Why?
|
Dizziness | 1 | 2023 | 251 | 0.050 |
Why?
|
Kv Channel-Interacting Proteins | 1 | 2000 | 56 | 0.050 |
Why?
|
Mathematical Computing | 1 | 2001 | 147 | 0.050 |
Why?
|
Disability Evaluation | 1 | 2008 | 1824 | 0.050 |
Why?
|
Software | 5 | 2006 | 4423 | 0.050 |
Why?
|
C-Reactive Protein | 1 | 2012 | 3752 | 0.050 |
Why?
|
Quantitative Trait, Heritable | 1 | 2003 | 545 | 0.050 |
Why?
|
Drug Repositioning | 1 | 2022 | 232 | 0.050 |
Why?
|
Patient Care | 1 | 2006 | 638 | 0.050 |
Why?
|
Medical Informatics | 1 | 2007 | 740 | 0.050 |
Why?
|
Antigens, CD | 1 | 2011 | 4024 | 0.050 |
Why?
|
Sensitivity and Specificity | 4 | 2014 | 14740 | 0.050 |
Why?
|
Genetic Variation | 2 | 2012 | 6539 | 0.050 |
Why?
|
Analysis of Variance | 3 | 2008 | 6370 | 0.050 |
Why?
|
Smoking | 3 | 2023 | 8960 | 0.040 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2015 | 3233 | 0.040 |
Why?
|
Vitamin B 12 | 1 | 2023 | 527 | 0.040 |
Why?
|
Hyperthyroidism | 1 | 2002 | 293 | 0.040 |
Why?
|
Information Dissemination | 2 | 2021 | 1106 | 0.040 |
Why?
|
Computer Simulation | 3 | 2007 | 6237 | 0.040 |
Why?
|
Intracranial Thrombosis | 1 | 2000 | 112 | 0.040 |
Why?
|
Motivation | 1 | 2009 | 1965 | 0.040 |
Why?
|
Autopsy | 2 | 2014 | 1004 | 0.040 |
Why?
|
State Medicine | 1 | 2021 | 219 | 0.040 |
Why?
|
Societies, Medical | 1 | 2011 | 3739 | 0.040 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2001 | 404 | 0.040 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2010 | 3344 | 0.040 |
Why?
|
Gene Expression | 1 | 2012 | 7788 | 0.040 |
Why?
|
Treatment Failure | 1 | 2005 | 2614 | 0.040 |
Why?
|
Thiazoles | 2 | 2017 | 1488 | 0.040 |
Why?
|
Apolipoproteins | 1 | 2021 | 315 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2022 | 11699 | 0.040 |
Why?
|
Brief Psychiatric Rating Scale | 2 | 2008 | 108 | 0.040 |
Why?
|
Ultrasonic Therapy | 1 | 2000 | 235 | 0.040 |
Why?
|
Germany | 1 | 2001 | 853 | 0.040 |
Why?
|
Presenilin-2 | 1 | 1998 | 106 | 0.040 |
Why?
|
Meat | 1 | 2021 | 594 | 0.040 |
Why?
|
Body Mass Index | 2 | 2014 | 12655 | 0.040 |
Why?
|
Mendelian Randomization Analysis | 1 | 2023 | 950 | 0.040 |
Why?
|
Introns | 1 | 2000 | 992 | 0.040 |
Why?
|
Speech | 1 | 2022 | 545 | 0.040 |
Why?
|
Narration | 1 | 2020 | 213 | 0.040 |
Why?
|
Organ Size | 2 | 2017 | 2247 | 0.040 |
Why?
|
Magnetics | 1 | 2000 | 609 | 0.040 |
Why?
|
Panic Disorder | 2 | 2002 | 617 | 0.040 |
Why?
|
Siblings | 3 | 2007 | 853 | 0.040 |
Why?
|
Chi-Square Distribution | 2 | 2016 | 3510 | 0.040 |
Why?
|
Reference Standards | 1 | 2021 | 1018 | 0.040 |
Why?
|
Survival Analysis | 3 | 2007 | 10247 | 0.040 |
Why?
|
Medical Records | 1 | 2022 | 1413 | 0.040 |
Why?
|
Hypothyroidism | 1 | 2002 | 659 | 0.040 |
Why?
|
Reading | 1 | 2021 | 554 | 0.040 |
Why?
|
Genetic Counseling | 1 | 2000 | 601 | 0.040 |
Why?
|
Prognosis | 6 | 2017 | 28901 | 0.040 |
Why?
|
Benzodiazepines | 1 | 2022 | 1099 | 0.040 |
Why?
|
Hospitals, University | 2 | 2009 | 567 | 0.040 |
Why?
|
Dysthymic Disorder | 1 | 1996 | 74 | 0.040 |
Why?
|
Genes | 1 | 2000 | 1898 | 0.040 |
Why?
|
Institutionalization | 2 | 2007 | 104 | 0.030 |
Why?
|
Ethylene Glycols | 1 | 2017 | 156 | 0.030 |
Why?
|
Blood Pressure Determination | 1 | 2019 | 630 | 0.030 |
Why?
|
Disclosure | 1 | 2022 | 735 | 0.030 |
Why?
|
Mothers | 1 | 2006 | 2143 | 0.030 |
Why?
|
Biomedical Research | 1 | 2011 | 3301 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2003 | 1778 | 0.030 |
Why?
|
Likelihood Functions | 1 | 1999 | 1004 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2017 | 15194 | 0.030 |
Why?
|
Massachusetts | 2 | 2021 | 8669 | 0.030 |
Why?
|
New Jersey | 1 | 2015 | 289 | 0.030 |
Why?
|
Independent Living | 1 | 2019 | 559 | 0.030 |
Why?
|
Sex Distribution | 1 | 2020 | 2296 | 0.030 |
Why?
|
Video Recording | 1 | 2020 | 936 | 0.030 |
Why?
|
Quality-Adjusted Life Years | 1 | 2021 | 1689 | 0.030 |
Why?
|
Secondary Prevention | 1 | 2021 | 1516 | 0.030 |
Why?
|
Chromosomes, Human, Pair 19 | 2 | 2007 | 366 | 0.030 |
Why?
|
Life Expectancy | 1 | 2021 | 1208 | 0.030 |
Why?
|
Presenilin-1 | 1 | 1998 | 635 | 0.030 |
Why?
|
Nerve Net | 1 | 2006 | 2179 | 0.030 |
Why?
|
Age Distribution | 1 | 2020 | 2904 | 0.030 |
Why?
|
Pennsylvania | 1 | 2015 | 615 | 0.030 |
Why?
|
Practice Guidelines as Topic | 1 | 2011 | 7274 | 0.030 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2006 | 2393 | 0.030 |
Why?
|
Fiji | 1 | 2013 | 47 | 0.030 |
Why?
|
Magnetic Resonance Angiography | 1 | 2000 | 1441 | 0.030 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2017 | 474 | 0.030 |
Why?
|
Energy Intake | 1 | 2021 | 2135 | 0.030 |
Why?
|
DNA | 3 | 2003 | 7275 | 0.030 |
Why?
|
Dietary Fats | 1 | 2021 | 2013 | 0.030 |
Why?
|
Cost-Benefit Analysis | 2 | 2021 | 5462 | 0.030 |
Why?
|
Cell Cycle Proteins | 1 | 2005 | 3433 | 0.030 |
Why?
|
Memory, Short-Term | 1 | 2020 | 974 | 0.030 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2017 | 2833 | 0.030 |
Why?
|
Psychiatry | 1 | 2005 | 1686 | 0.030 |
Why?
|
Self Report | 2 | 2014 | 3524 | 0.030 |
Why?
|
Inflammation | 1 | 2012 | 10534 | 0.030 |
Why?
|
Family Health | 3 | 2004 | 1281 | 0.030 |
Why?
|
Evoked Potentials | 1 | 2018 | 1057 | 0.030 |
Why?
|
Databases, Bibliographic | 1 | 2012 | 129 | 0.030 |
Why?
|
Decision Support Systems, Clinical | 1 | 2021 | 1162 | 0.030 |
Why?
|
Health Status | 2 | 2021 | 4013 | 0.030 |
Why?
|
Diagnostic Self Evaluation | 1 | 2014 | 232 | 0.030 |
Why?
|
Bayes Theorem | 2 | 2011 | 2303 | 0.030 |
Why?
|
Sweden | 1 | 2015 | 1336 | 0.030 |
Why?
|
Multivariate Analysis | 3 | 2008 | 12237 | 0.030 |
Why?
|
Monte Carlo Method | 2 | 2011 | 1279 | 0.030 |
Why?
|
Treatment Outcome | 4 | 2010 | 62693 | 0.030 |
Why?
|
Verbal Learning | 1 | 2014 | 466 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2020 | 12948 | 0.020 |
Why?
|
Attitude of Health Personnel | 1 | 2005 | 3844 | 0.020 |
Why?
|
Visual Perception | 1 | 2020 | 1418 | 0.020 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 2014 | 547 | 0.020 |
Why?
|
Association | 1 | 2011 | 53 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 2 | 2014 | 6516 | 0.020 |
Why?
|
Morbidity | 1 | 1996 | 1763 | 0.020 |
Why?
|
Anxiety Disorders | 1 | 2002 | 2674 | 0.020 |
Why?
|
Multifactorial Inheritance | 1 | 2018 | 1174 | 0.020 |
Why?
|
Adolescent | 7 | 2018 | 85405 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2022 | 2861 | 0.020 |
Why?
|
Retrospective Studies | 4 | 2023 | 76631 | 0.020 |
Why?
|
Dietary Supplements | 1 | 2023 | 3279 | 0.020 |
Why?
|
Chromosome Segregation | 1 | 2011 | 236 | 0.020 |
Why?
|
Acute Disease | 1 | 2000 | 7128 | 0.020 |
Why?
|
Socioeconomic Factors | 3 | 2008 | 7726 | 0.020 |
Why?
|
Insurance Claim Review | 1 | 2014 | 720 | 0.020 |
Why?
|
DNA Mutational Analysis | 2 | 2009 | 4182 | 0.020 |
Why?
|
Clinical Competence | 1 | 2005 | 4671 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2023 | 3614 | 0.020 |
Why?
|
Sex Factors | 2 | 2014 | 10398 | 0.020 |
Why?
|
Wechsler Scales | 1 | 2009 | 259 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2000 | 4400 | 0.020 |
Why?
|
Residence Characteristics | 2 | 2011 | 2041 | 0.020 |
Why?
|
Health Behavior | 1 | 2021 | 2624 | 0.020 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2004 | 3636 | 0.020 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 2010 | 769 | 0.020 |
Why?
|
Decision Making | 1 | 2022 | 3854 | 0.020 |
Why?
|
Cleft Lip | 1 | 2013 | 474 | 0.020 |
Why?
|
Mental Disorders | 2 | 2005 | 6570 | 0.020 |
Why?
|
Quality of Life | 1 | 2009 | 12640 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2005 | 9622 | 0.020 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2008 | 300 | 0.020 |
Why?
|
Health Status Indicators | 1 | 2013 | 969 | 0.020 |
Why?
|
Mass Screening | 1 | 2023 | 5265 | 0.020 |
Why?
|
Prosopagnosia | 1 | 2008 | 60 | 0.020 |
Why?
|
Multigene Family | 1 | 2011 | 1107 | 0.020 |
Why?
|
Comorbidity | 3 | 2009 | 10362 | 0.020 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2009 | 374 | 0.020 |
Why?
|
Molecular Sequence Data | 1 | 2000 | 18125 | 0.020 |
Why?
|
Personality Assessment | 1 | 2009 | 643 | 0.020 |
Why?
|
Diagnostic Errors | 1 | 1994 | 1253 | 0.020 |
Why?
|
Confusion | 1 | 2009 | 271 | 0.020 |
Why?
|
Technetium Tc 99m Exametazime | 1 | 2006 | 71 | 0.020 |
Why?
|
Mental Health | 1 | 2021 | 2946 | 0.020 |
Why?
|
Orthopedic Equipment | 1 | 2006 | 22 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2016 | 5058 | 0.020 |
Why?
|
Syncope | 1 | 2009 | 431 | 0.020 |
Why?
|
Sex Characteristics | 1 | 1996 | 2583 | 0.020 |
Why?
|
Hypokinesia | 1 | 2005 | 17 | 0.020 |
Why?
|
Transcription Factors | 1 | 2005 | 12120 | 0.020 |
Why?
|
Muscle Rigidity | 1 | 2005 | 35 | 0.020 |
Why?
|
Phosphorylation | 1 | 2017 | 8416 | 0.020 |
Why?
|
Dysarthria | 1 | 2005 | 55 | 0.020 |
Why?
|
Meta-Analysis as Topic | 1 | 2010 | 1339 | 0.020 |
Why?
|
Borderline Personality Disorder | 1 | 1992 | 735 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2013 | 4935 | 0.020 |
Why?
|
Schizophrenic Psychology | 1 | 1992 | 1677 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2017 | 13816 | 0.020 |
Why?
|
Calcium Channels | 1 | 2008 | 621 | 0.020 |
Why?
|
Equipment Failure Analysis | 1 | 2007 | 867 | 0.020 |
Why?
|
Behavioral Symptoms | 1 | 2006 | 174 | 0.020 |
Why?
|
Receptors, Oxidized LDL | 1 | 2004 | 2 | 0.020 |
Why?
|
Scavenger Receptors, Class E | 1 | 2004 | 8 | 0.020 |
Why?
|
Dominance, Cerebral | 1 | 2006 | 635 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2010 | 2974 | 0.020 |
Why?
|
Mutation | 2 | 2012 | 29658 | 0.020 |
Why?
|
Factor Analysis, Statistical | 1 | 2007 | 976 | 0.020 |
Why?
|
Length of Stay | 1 | 2017 | 6295 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 2009 | 1583 | 0.010 |
Why?
|
Twins, Dizygotic | 1 | 2004 | 235 | 0.010 |
Why?
|
Young Adult | 3 | 2018 | 56255 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 1993 | 2716 | 0.010 |
Why?
|
Genetics, Population | 1 | 2008 | 931 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9314 | 0.010 |
Why?
|
Death | 1 | 2007 | 670 | 0.010 |
Why?
|
Professional Practice | 1 | 2005 | 327 | 0.010 |
Why?
|
Regional Blood Flow | 1 | 2006 | 1528 | 0.010 |
Why?
|
Drug Therapy | 1 | 2006 | 497 | 0.010 |
Why?
|
Gait Disorders, Neurologic | 1 | 2005 | 230 | 0.010 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2005 | 657 | 0.010 |
Why?
|
Overweight | 1 | 2014 | 2355 | 0.010 |
Why?
|
Twins, Monozygotic | 1 | 2004 | 457 | 0.010 |
Why?
|
Costs and Cost Analysis | 1 | 2008 | 1675 | 0.010 |
Why?
|
RNA | 1 | 2012 | 2723 | 0.010 |
Why?
|
Amino Acid Substitution | 1 | 2007 | 1793 | 0.010 |
Why?
|
Neurologic Examination | 1 | 2005 | 932 | 0.010 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2005 | 562 | 0.010 |
Why?
|
Risk | 1 | 2014 | 9684 | 0.010 |
Why?
|
Butyrylcholinesterase | 1 | 2000 | 22 | 0.010 |
Why?
|
Corpus Callosum | 1 | 2006 | 739 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2017 | 9387 | 0.010 |
Why?
|
Hospitalization | 2 | 2014 | 10208 | 0.010 |
Why?
|
Child | 3 | 2008 | 77033 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2010 | 6478 | 0.010 |
Why?
|
Amyloid Precursor Protein Secretases | 1 | 2004 | 583 | 0.010 |
Why?
|
Observer Variation | 1 | 2006 | 2589 | 0.010 |
Why?
|
Education, Medical, Continuing | 1 | 2005 | 840 | 0.010 |
Why?
|
Phobic Disorders | 1 | 2002 | 438 | 0.010 |
Why?
|
RNA Splice Sites | 1 | 2000 | 209 | 0.010 |
Why?
|
Neurodegenerative Diseases | 1 | 2008 | 1050 | 0.010 |
Why?
|
Social Environment | 1 | 2004 | 1014 | 0.010 |
Why?
|
Equipment Design | 1 | 2007 | 3583 | 0.010 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2013 | 3029 | 0.010 |
Why?
|
Radiation Dosage | 1 | 2007 | 1920 | 0.010 |
Why?
|
Isoleucine | 1 | 1998 | 111 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2009 | 2749 | 0.010 |
Why?
|
Attention | 1 | 2009 | 2400 | 0.010 |
Why?
|
Microsatellite Repeats | 1 | 2000 | 797 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2015 | 9812 | 0.010 |
Why?
|
Physician's Role | 1 | 2005 | 943 | 0.010 |
Why?
|
Health Surveys | 1 | 2008 | 4022 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2012 | 11985 | 0.010 |
Why?
|
Cerebrovascular Circulation | 1 | 2008 | 2757 | 0.010 |
Why?
|
Cholesterol, HDL | 1 | 2003 | 1807 | 0.010 |
Why?
|
Child, Preschool | 1 | 2019 | 40802 | 0.010 |
Why?
|
Valine | 1 | 1998 | 413 | 0.010 |
Why?
|
Interleukin-1 | 1 | 2000 | 1262 | 0.010 |
Why?
|
Radiopharmaceuticals | 1 | 2006 | 2687 | 0.010 |
Why?
|
Sequence Deletion | 1 | 2000 | 1528 | 0.010 |
Why?
|
Triglycerides | 1 | 2003 | 2447 | 0.010 |
Why?
|
Electroencephalography | 1 | 2009 | 6133 | 0.010 |
Why?
|
Schizophrenia | 1 | 1992 | 6866 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2005 | 4791 | 0.010 |
Why?
|
Alcohol Drinking | 1 | 2004 | 3945 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2005 | 7709 | 0.010 |
Why?
|
Blood Glucose | 1 | 2003 | 6237 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2000 | 5863 | 0.010 |
Why?
|
Registries | 1 | 2004 | 8039 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2012 | 20055 | 0.010 |
Why?
|
Pregnancy | 1 | 2006 | 29002 | 0.000 |
Why?
|